Susquehanna International Group, LLP Morpho Sys Ag Put Options Transaction History

Susquehanna International Group, LLP

  • $568 Billion
  • Q1 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2024

May 07, 2024
SELL
$8.6 - $18.18 $240,800 - $509,040
-28,000 Reduced 6.9%
377,800 $6.85 Million
Q4 2023

Feb 14, 2024
BUY
$4.55 - $9.9 $1.77 Million - $3.86 Million
389,700 Added 2420.5%
405,800 $4.02 Million
Q3 2023

Nov 14, 2023
BUY
$6.72 - $8.6 $34,944 - $44,720
5,200 Added 47.71%
16,100 $108,000
Q2 2023

Aug 11, 2023
BUY
$3.95 - $7.74 $43,055 - $84,366
10,900 New
10,900 $81,000

Others Institutions Holding MOR

# of Institutions
72
Shares Held
11.3M
Call Options Held
320K
Put Options Held
1.1M
View Full List

About MorphoSys AG

MOR Quotes by TradingView
  • Ticker MOR
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 136,614,000
  • Market Cap $2.47B
  • Description
  • MorphoSys AG, a commercial-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic antibodies for patients suffering from cancer and autoimmune diseases in the United States. It offers Tafasitamab, an antibody for the treatment of B cell malignancies, including diffuse large B-cell lymphoma, f...
More about MOR
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email